Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | - |
Mus musculus | 16020 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
arachidonoyl-CoA + 1-acyl-lysophosphatidylinositol | Mus musculus | - |
CoA + 1-acyl-2-arachidonoyl-lysophosphatidylinositol | - |
? | |
eicosapentaenoyl-CoA + 1-acyl-lysophosphatidylinositol | Mus musculus | - |
CoA + 1-acyl-2-eicosapentaenoyl-lysophosphatidylinositol | - |
? | |
additional information | Mus musculus | LPIAT1 prefers 20:4-CoA and 20:5-CoA as donors | ? | - |
- |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | Q8CHK3 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
arachidonoyl-CoA + 1-acyl-lysophosphatidylinositol | - |
Mus musculus | CoA + 1-acyl-2-arachidonoyl-lysophosphatidylinositol | - |
? | |
eicosapentaenoyl-CoA + 1-acyl-lysophosphatidylinositol | - |
Mus musculus | CoA + 1-acyl-2-eicosapentaenoyl-lysophosphatidylinositol | - |
? | |
additional information | LPIAT1 prefers 20:4-CoA and 20:5-CoA as donors | Mus musculus | ? | - |
- |
Synonyms | Comment | Organism |
---|---|---|
LPIAT1 | - |
Mus musculus |
LPLAT 7 | - |
Mus musculus |
lysophosphatidylinositol-acyltransferase-1 | - |
Mus musculus |
lysophospholipid acyltransferase 7 | - |
Mus musculus |
MBOAT7 | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
evolution | the enzyme belongs to the MBOAT family | Mus musculus |
malfunction | LPIAT1 deficiency induces abnormal brain morphology, delays neural migration, and reduces neurite outgrowth in mice. The size of LPIAT1-KO mice is significantly smaller than that of their littermates. The frequency of mice carrying the knockout mutation is lower than that expected by Mendelian genetics. Rs641738, a polymorphism in the LPIAT1 (MBOAT7) locus is reported to associate with hepatic inflammation and increased risk of fibrosis, nonalcoholic fatty liver disease, and alcohol related cirrhosis. This variant decreases LPIAT1 expression in the liver and changes PI compositions in the plasma. Other mutations are also reported to lead to intellectual disability, suggesting the importance of AA-containing phosphatidylinositol in the disease development | Mus musculus |
metabolism | phospholipase A2 (PLA2) plays a role in membrane phospholipid remodeling by coupling with re-acylation processes mediated by lysophospholipid acyltransferases (LPLATs) to generate sn-1/sn-2 fatty acid asymmetry of phospholipids. Lysophospholipids are acylated by LPLAT to generate phospholipids phosphatidic acid (PA), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylglycerol (PG), and cardiolipin (CL) by LPLATs. In the Kennedy pathway, glycerol-3-phosphate (G3P) is first acylated by glycerol-phosphate acyltransferase (GPAT) to form lyso-PA (LPA), which is subsequently converted to PA by LPA-acyltransferase (LPAAT) | Mus musculus |